ResearcherVilnius UniversityNo recent work listed
Mindaugas Valius
Matched on ORCID iD 0000-0001-8478-8517; OpenAlex author ID A5039779326. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers
Papers 3
- Establishment and Characterization of a New Pancreatic Ductal Adenocarcinoma Cell Line Capan-26. Last author DOI 10.21873/anticanres.14897↗
- CEACAM6's Role as a Chemoresistance and Prognostic Biomarker for Pancreatic Cancer: A Comparison of CEACAM6's Diagnostic and Prognostic Capabilities with Those… Co-author DOI 10.3390/life11060542↗
- Proteomic Identification of FLT3 and PCBP3 as Potential Prognostic Biomarkers for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.12914↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Benediktas Kurlinkus · 3 shared papers, 2018–2021 · strength 0.40
- Paper Establishment and Characterization of a New Pancreatic Ductal Adenocarcinoma Cell Line Capan-26. DOI 10.21873/anticanres.14897↗
- Paper CEACAM6's Role as a Chemoresistance and Prognostic Biomarker for Pancreatic Cancer: A Comparison of CEACAM6's Diagnosti… DOI 10.3390/life11060542↗
- Paper Proteomic Identification of FLT3 and PCBP3 as Potential Prognostic Biomarkers for Pancreatic Cancer. DOI 10.21873/anticanres.12914↗
- Audrius Šileikis · 3 shared papers, 2018–2021 · strength 0.40
- Paper Establishment and Characterization of a New Pancreatic Ductal Adenocarcinoma Cell Line Capan-26. DOI 10.21873/anticanres.14897↗
- Paper CEACAM6's Role as a Chemoresistance and Prognostic Biomarker for Pancreatic Cancer: A Comparison of CEACAM6's Diagnosti… DOI 10.3390/life11060542↗
- Paper Proteomic Identification of FLT3 and PCBP3 as Potential Prognostic Biomarkers for Pancreatic Cancer. DOI 10.21873/anticanres.12914↗
- Marija Ger · 2 shared papers, 2018–2021 · strength 0.24
- Peter Schemmer · 1 shared paper, 2021 · strength 0.16
- Eglė Žalytė · 1 shared paper, 2021 · strength 0.16
- Kęstutis Strupas · 1 shared paper, 2018 · strength 0.09
- Jonas Cicenas · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.